GRANULES vs TORNTPHARM: Stock Comparison

Granules India Limited vs Torrent Pharmaceuticals LtdUpdated 21 Aug 26, 4:08 PM ISTNSE & company filings

Torrent Pharmaceuticals Ltd is the larger company by market capitalisation. Granules India Limited shows a lower P/E, lower leverage and a higher ROCE, while Torrent Pharmaceuticals Ltd shows a higher ROE, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

GRANULES leads 6; TORNTPHARM leads 7 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

GRANULESTORNTPHARM

Valuation lens

What price are you paying?

Market CapContext only
₹21,277 Cr
₹1.87 L Cr
P/E RatioGRANULES has the lower reading
31.82x
75.74x
P/B RatioGRANULES has the lower reading
4.18x
19.69x
EPSTORNTPHARM has the higher reading
₹26.95
₹63.7
Book ValueContext only
₹205.21
₹248
Dividend YieldTORNTPHARM has the higher reading
0.2%
0.74%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
TORNTPHARM is the larger company
₹1.87 L Cr vs ₹21,277 Cr
P/E Ratio
GRANULES has a lower P/E
31.82x vs 75.74x
P/B Ratio
GRANULES has a lower P/B
4.18x vs 19.69x
EPS
TORNTPHARM has higher earnings per share
₹63.7 vs ₹26.95
Dividend Yield
TORNTPHARM has a higher dividend yield
0.74% vs 0.2%
Revenue Growth (TTM YoY)
TORNTPHARM has faster revenue growth
41.8% vs 22.8%
EPS Growth (TTM YoY)
GRANULES has faster EPS growth
31.3% vs -21.7%
Qtr Sales Growth
TORNTPHARM has stronger quarterly sales growth
54.8% vs 22.8%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricGRANULESTORNTPHARM
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricGRANULESTORNTPHARM
Live Price₹858.15₹4,896.5
Day Change1.97%-2.17%
Volume4.06 L2.26 L
52-Week High₹910₹5,250
52-Week Low₹454.75₹3,480.6
Distance from 52W High-5.7%-6.73%

Valuation

MetricGRANULESTORNTPHARM
Market Cap₹21,277 Cr₹1.87 L Cr
P/E Ratio31.82x75.74x
P/B Ratio4.18x19.69x
EPS₹26.95₹63.7
Book Value₹205.21₹248
Dividend Yield0.2%0.74%

Growth

MetricGRANULESTORNTPHARM
Revenue Growth (TTM YoY)22.8%41.8%
EPS Growth (TTM YoY)31.3%-21.7%
Qtr Sales Growth22.8%54.8%
Qtr Profit Growth44.6%5.79%

Profitability & Leverage

MetricGRANULESTORNTPHARM
ROE13.7%27.4%
ROCE15.5%15.2%
Net Margin11.15%15.73%
Operating Margin22.1%33%
Debt to Equity0.3x1.79x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricGRANULESTORNTPHARM
Promoter Holding37.67%60.78% 7.53 pp
FII Holding17.5% 2.19 pp17.97% 2.53 pp
DII Holding16.11% 0.9 pp12.87% 3.04 pp
Public Holding28.38% 1.28 pp8.38% 1.96 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Granules India Limited and Torrent Pharmaceuticals Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.